AVITA Medical's Australian shares jump after Q2 revenue tops estimates

AVITA Medical

11/08/2023 04:00

** ASX-listed shares of U.S.-based AVITA Medical  RCEL.O 
 AVH.AX  jump as much as 6.03% to A$5.67, highest since July 31
    ** The regenerative medicine co reports qtrly revenue of
$11.7 mln, beating analysts' estimate of $11.3 mln
    ** Co raises full-year commercial revenue guidance to a
range of $51 to $53 mln from $49 to $51 mln 
    ** Reports Q2 net loss of $10.4 mln, or a loss of $0.41 per
share, compared with a net loss of $6.3 mln , or a loss of $0.25
per share, a year earlier 
    ** Stock up 179.1% this year, as of last close

 (Reporting by Aishwarya Nair in Bengaluru)
 ((Aishwarya.Nair@thomsonreuters.com; +91-9167838937 Twitter: https://twitter.com/Aishwaryartrs
 ;))